97 related articles for article (PubMed ID: 25086267)
1. Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia.
Yu R; Yang Y; Cui Z; Zheng L; Zeng Z; Zhang H
Peptides; 2014 Oct; 60():41-50. PubMed ID: 25086267
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
Yu R; Zheng L; Cui Y; Zhang H; Ye H
Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
[TBL] [Abstract][Full Text] [Related]
3. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
[TBL] [Abstract][Full Text] [Related]
4. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
5. The TAT peptide endows PACAP with an enhanced ability to traverse bio-barriers.
Yu R; Zeng Z; Guo X; Zhang H; Liu X; Ding Y; Chen J
Neurosci Lett; 2012 Oct; 527(1):1-5. PubMed ID: 22939769
[TBL] [Abstract][Full Text] [Related]
6. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
7. TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP neuroprotective effect in the MPTP mouse model of Parkinson's disease.
Yu R; Li J; Lin Z; Ouyang Z; Huang X; Reglodi D; Vaudry D
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129626. PubMed ID: 32335135
[TBL] [Abstract][Full Text] [Related]
8. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
9. The novel peptide PACAP-TAT with enhanced traversing ability attenuates the severe lung injury induced by repeated smoke inhalation.
Yu R; Guo X; Huang L; Zeng Z; Zhang H
Peptides; 2012 Nov; 38(1):142-9. PubMed ID: 22982609
[TBL] [Abstract][Full Text] [Related]
10. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
12. The functional recombinant first extracellular (EC1) domain of PACAP receptor PAC1 normal form (PAC1-EC1(N)) recognizes selective ligands and stimulates the proliferation of PAC1-CHO cells.
Yu R; Li J; Wang J; Liu X; Huang L; Ding Y; Chen J
Neurosci Lett; 2010 Aug; 480(1):73-7. PubMed ID: 20553998
[TBL] [Abstract][Full Text] [Related]
13. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
[TBL] [Abstract][Full Text] [Related]
14. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
[TBL] [Abstract][Full Text] [Related]
15. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
16. PACAP and VIP prevent apoptosis in schwannoma cells.
Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
[TBL] [Abstract][Full Text] [Related]
17. Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity.
Sakamoto K; Koyama R; Kamada Y; Miwa M; Tani A
Biochem Biophys Res Commun; 2018 Sep; 503(3):1973-1979. PubMed ID: 30077368
[TBL] [Abstract][Full Text] [Related]
18. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
[TBL] [Abstract][Full Text] [Related]
19. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
20. PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance.
Jamen F; Persson K; Bertrand G; Rodriguez-Henche N; Puech R; Bockaert J; Ahrén B; Brabet P
J Clin Invest; 2000 May; 105(9):1307-15. PubMed ID: 10792006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
